Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.
Jay Bregman
Advertisement
Jay Bregman, founder and CEO of Andel
Articles by Jay Bregman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Retail Closures Threaten Pharmacy Access in Vulnerable Communities
2
Assistive Technology Can Reduce Disparities, Improve Safety Among Patients with Disabilities
3
Emerging Market Access Models Reshapes Drug Distribution
4
Review Details Chikungunya's Global Resurgence as US Surveillance Evolves
5